Tudor Investment Corp’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-42,583
| Closed | -$2.06M | – | 2103 |
|
|
2025
Q1 | $2.06M | Buy |
+42,583
| New | +$2.06M | 0.01% | 804 |
|
|
2024
Q4 | – | Sell |
-13,858
| Closed | -$624K | – | 1989 |
|
|
2024
Q3 | $624K | Buy |
+13,858
| New | +$624K | ﹤0.01% | 1165 |
|
|
2024
Q2 | – | Sell |
-22,510
| Closed | -$651K | – | 1885 |
|
|
2024
Q1 | $651K | Sell |
22,510
-6,276
| -22% | -$182K | ﹤0.01% | 1027 |
|
|
2023
Q4 | $660K | Buy |
+28,786
| New | +$660K | 0.01% | 1052 |
|
|
2023
Q3 | – | Sell |
-33,338
| Closed | -$921K | – | 1851 |
|
|
2023
Q2 | $921K | Sell |
33,338
-4,002
| -11% | -$111K | 0.01% | 936 |
|
|
2023
Q1 | $859K | Buy |
+37,340
| New | +$859K | 0.01% | 959 |
|
|
2022
Q4 | – | Sell |
-24,332
| Closed | -$205K | – | 1892 |
|
|
2022
Q3 | $205K | Buy |
+24,332
| New | +$205K | ﹤0.01% | 1413 |
|